Prodrugs of selective androgen receptor modulators and methods of use thereof
US7595402B2 · kind B2 · utility
3Cited by
18References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2004 |
| Grant date | Sep 29, 2009 |
| Priority date | — |
| Expiry date | Feb 8, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C235/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides prodrugs of selective androgen receptor modulators (SARMs), and their use in treating or reducing the incidence of osteoporosis, a variety of hormone-related conditions, conditions associated with Androgen Decline in Aging Male (ADAM); conditions associated with Androgen Decline in Female (ADIF), and muscular wasting conditions, obesity, dry eye conditions, and prostate cancer. The prodrugs are also useful in oral androgen replacement therapy and male contraception.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.